Global Animal Model Market to Reach USD 4.05 Billion by 2033 | Key Growth Drivers and Opportunities

The Animal Model Market is gaining traction as researchers and pharmaceutical companies increasingly rely on animal studies to understand disease mechanisms and test new drugs before human trials. Valued at USD 2.38 Billion in 2024, the market is projected to grow from USD 2.52 Billion in 2025 to USD 4.05 Billion by 2033, expanding at a CAGR of 6.11% during the forecast period.

📥 Download Sample Report

Why Animal Models Matter

Animal models play a crucial role in medical research due to their physiological and genetic similarities with humans. They help scientists study complex diseases, develop treatment methods, and ensure drug safety. Mice, rats, guinea pigs, and rabbits are among the most commonly used species. However, strict ethical guidelines and animal welfare regulations govern their usage in laboratories.

Market Drivers

• Rising demand in virology and infectious disease research: The emergence of pandemics like COVID-19 increased the use of mice and rat models for understanding viral pathogenesis and drug testing.
• CRISPR technology adoption: This gene-editing method enables quick and cost-effective creation of animal models, accelerating drug discovery and personalized medicine research.

Market Challenges

The biggest hurdle for the industry is compliance with global animal welfare and testing regulations. Many countries have already banned cosmetic testing on animals, pushing the market to evolve with more ethical frameworks.

Opportunities in Emerging Economies

Countries like India, China, and Japan are witnessing strong growth in pharmaceutical R&D, creating opportunities for animal model providers. Investments in healthcare infrastructure and rising demand for personalized medicine are further fueling market expansion.

Regional Insights

• North America dominates the global market with a projected CAGR of 6.2%, supported by strong government and private investments in biomedical research.
• Europe is set to reach USD 712 Million by 2033, driven by CRISPR adoption, pharma R&D, and preclinical trials.
• Asia-Pacific is expected to experience the fastest growth, backed by government initiatives, CRO expansions, and advanced healthcare infrastructure.
• LAMEA shows promising growth opportunities due to rising chronic disease prevalence and strengthening research institutions.

Animal Type Insights

• Rat models hold the largest market share, growing at a CAGR of 6.0%, widely used in cardiovascular, neurological, and toxicology studies.
• Mice models remain critical for genetic, aging, and virology research with increasing demand for humanized mice.
• Guinea pigs are gaining traction in asthma, Alzheimer’s, and metabolic disorder studies.

Application & End-User Insights

• Drug discovery and development leads with a CAGR of 6.6%, making animal models vital in preclinical testing and safety evaluations.
• Pharma and biotech companies dominate end-user adoption with a CAGR of 6.7%, followed by academic research institutes leveraging models for genetics and disease studies.

Key Players in the Animal Model Market

• Charles River Laboratories
• The Jackson Laboratory
• Genoway S.A
• Taconic Biosciences, Inc.
• Janvier Labs
• Harbour BioMed
• Crown Bioscience
• Envigo RMS, LLC
• Inotiv
• BIOCYTOGEN
• BioSpherix, Ltd.
• Ozgene Pty
• Trans Genic Inc
• Hera Biolabs
• B&K Universal

Recent Developments

• March 2022: Hera BioLabs partnered with Charles River Laboratories to market SRGTM rat models for oncology and infectious disease studies.
• April 2022: Taconic Biosciences and Biomodels launched the TBMI initiative to expand microbiome study solutions.
• June 2022: The Jackson Laboratory introduced a new methylome profiling approach for better classification of CNS tumors.

Conclusion

The global animal model market is evolving rapidly with advancements in CRISPR technology, increasing demand for personalized medicine, and expanding research in emerging markets. While ethical concerns and regulations present challenges, the market’s projected growth to USD 4.05 Billion by 2033 reflects its crucial role in shaping the future of medical and pharmaceutical research.

About Us

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)

Website: https://straitsresearch.com/